Successful Growth of Functional Thymus Organoids from Human Stem Cells
The thymus, a crucial organ for adaptive immune response, produces T cells that attack invaders. With age and certain diseases, the thymus degrades, affecting immunity. Scientists from the University of Florida have grown functional thymus organoids from human stem cells for the first time, potentially aiding the development of patient-specific therapies for thymic dysfunction. Although […]
BrainStorm Cell Therapeutics Announces FDA Advisory Committee Meeting to Review Biologics License Application for NurOwn® for the Treatment of ALS
NEW YORK, March 27, 2023 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) will hold an Advisory Committee Meeting (‘ADCOM’) to discuss the company’s Biologics License Application (BLA) for NurOwn® for the treatment of amyotrophic lateral sclerosis (ALS). Given the […]
Genes that Form Specific Bones In the Womb Heal them Later in Life
NEW YORK, March 20, 2023 /PRNewswire/ — Genes long known to control the formation of bones before birth also control bone healing later in life, a new study found. Led by researchers at NYU Langone Health, a new study pinpointed key Hox genes, specific to each location in the body, as the controllers of stem cells […]
WWE Star Tommaso Ciampa Receives Final Stem Cell Treatment to Speed Up Recovery
WWE wrestler Tommaso Ciampa recently underwent his final stem cell treatment, as he continues to recover from multiple nagging injuries sustained during his in-ring career. Ciampa had been out of action since September and revealed on Instagram last week that he had traveled to Medellin, Colombia, to receive stem cell treatments from BioXcellerator, a leader […]
Positive Echocardiography Data from BioCardia Phase III CardiAMP Cell Therapy Heart Failure Trial Presented at American College of Cardiology Annual Meeting
SUNNYVALE, Calif., March 06, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announces that detailed echocardiography data from the roll-in cohort of the Phase III CardiAMP® Cell Therapy Heart Failure Trial is being presented today at the American College of Cardiology annual meeting by […]
Another Patient Cleared of HIV with Stem Cell Transplant
A 53-year-old man in Germany, referred to as the ‘Düsseldorf patient’, has become the fifth person to be declared cleared of HIV after a bone marrow transplant that replaced his cells with HIV-resistant stem cells from a donor. The procedure was first used on Timothy Ray Brown, the ‘Berlin patient,’ in 2007, and later on […]
Gameto licenses Wyss Institute’s technology for growing human ovaries from Harvard University
BOSTON, MA, Feb. 21, 2023 (GLOBE NEWSWIRE) — Despite the fact that we all start out as an egg cell in one of our mother’s ovaries, these human reproductive organs are surprisingly under-studied. Scientists have been working on creating in vitro models of human ovaries so that we can learn more about them and develop treatments for […]
StemBioSys Announces Launch of NeuroMatrix™, a Technological Leap Forward in Laboratory Production of Functionally Mature Human Neural Cell Types
SAN ANTONIO, Feb. 13, 2023 /PRNewswire/ — StemBioSys, Inc. (StemBioSys) announced today the launch of NeuroMatrix™, an astrocyte-derived extracellular matrix that enables the culture of human induced pluripotent stem cell (hiPSC) derived and primary neural cell types. StemBioSys designed NeuroMatrix™ to expand the use of iPSC-derived neurons in drug discovery and toxicity testing. “NeuroMatrix™ represents a breakthrough in hiPSC-derived neuronal development […]
Kytopen and Mirus Bio Announce Partnership to Unlock New and Scalable Genome Engineering Capabilities for the Next-Generation of Living Medicines
CAMBRIDGE, Mass., Jan. 31, 2023 /PRNewswire/ — Kytopen, a biotechnology company leading advancements in high-throughput cellular and genome engineering platforms, today announced a partnership with the pioneering transfection company, Mirus Bio, pairing their technologies to resolve challenges related to the delivery of complex genetic materials to living human cells. “Gene-modified cell therapies hold great promise for patients. […]
Cell BioEngines Enters into an Exclusive Worldwide Agreement to Develop and Commercialize Potent Immune Cell States to Cure Cancer
BOSTON and NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) — Cell BioEngines Inc. (the “Company”), a cell and gene therapy company focused on developing an allogenic cell-based product for solid tumors, today announced that it has entered into an exclusive license agreement with Icahn School of Medicine at Mount Sinai (“Icahn Mount Sinai”), in New […]